Effect of lawsuits on stock price compared to product withdrawal: a focus on the consequences of Vioxx's adverse effects

Simple item page
dc.contributor.committeeChairXu, Ke Tom
dc.contributor.committeeMemberSteinmeier, Thomas L.
dc.creatorWatson, Kimberly S.
dc.date.accessioned2016-11-14T23:23:57Z
dc.date.available2011-02-18T21:44:08Z
dc.date.available2016-11-14T23:23:57Z
dc.date.issued2006-08
dc.degree.departmentEconomicsen_US
dc.description.abstractPharmaceutical companies are plagued with lawsuits in today’s society. Some companies will hastily remove a product from the market before the negative side effects of the drug can be fully established for fear of severe losses due to lawsuits. Lawsuits will occur whether the drug is left on the market or not, as seen with the multiple cases both decided and pending against Merck for their drug, Vioxx. Using stock analysis as a measurement, it is evident in the case of Vioxx that removing a product from market will have a more detrimental effect on the manufacturer than the lawsuits will. In the cases where a drug could ethically be left on the market with additional warnings for those that may experience negative side effects, it is better for the company to continue to market the product and endure the lawsuits than remove the product and face the lawsuits alone.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttp://hdl.handle.net/2346/16814en_US
dc.language.isoeng
dc.publisherTexas Tech Universityen_US
dc.rights.availabilityUnrestricted.
dc.subjectWithdrawalen_US
dc.subjectProducten_US
dc.subjectStocksen_US
dc.subjectLawsuitsen_US
dc.subjectRofecoxiben_US
dc.titleEffect of lawsuits on stock price compared to product withdrawal: a focus on the consequences of Vioxx's adverse effects
dc.typeThesis

Files

Collections

Texas Tech University